Andlauer Healthcare Group Inc. (TSE:AND) Announces Dividend Increase – $0.08 Per Share

Andlauer Healthcare Group Inc. (TSE:AND – Get Rating) declared a quarterly dividend on Wednesday, March 15th, Zacks reports. Shareholders of record on Friday, March 31st will be given a dividend of 0.08 per share on Monday, April 17th. This represents a $0.32 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date is Thursday, March 30th. This is an increase from Andlauer Healthcare Group’s previous quarterly dividend of $0.07.

Andlauer Healthcare Group Price Performance

Shares of AND stock opened at C$46.51 on Friday. The company has a debt-to-equity ratio of 37.03, a quick ratio of 1.66 and a current ratio of 2.01. Andlauer Healthcare Group has a fifty-two week low of C$37.57 and a fifty-two week high of C$55.97. The firm has a market cap of C$933.46 million, a P/E ratio of 25.98 and a beta of 0.66. The business’s 50 day moving average price is C$47.17 and its 200-day moving average price is C$48.99.

Andlauer Healthcare Group (TSE:AND – Get Rating) last released its quarterly earnings results on Thursday, March 2nd. The company reported C$0.46 earnings per share for the quarter. Andlauer Healthcare Group had a net margin of 11.76% and a return on equity of 19.23%. The business had revenue of C$165.77 million for the quarter. On average, equities research analysts anticipate that Andlauer Healthcare Group will post 1.7904762 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages have commented on AND. Scotiabank raised their price objective on shares of Andlauer Healthcare Group from C$53.00 to C$55.00 in a report on Monday, January 23rd. TD Securities increased their price objective on Andlauer Healthcare Group from C$57.00 to C$58.00 and gave the stock a “hold” rating in a report on Monday, March 6th. Royal Bank of Canada raised their price objective on Andlauer Healthcare Group from C$47.00 to C$48.00 and gave the company a “sector perform” rating in a research report on Monday, March 6th. CIBC reduced their target price on shares of Andlauer Healthcare Group from C$59.00 to C$54.00 and set a “neutral” rating on the stock in a research report on Wednesday, January 18th. Finally, Eight Capital set a C$62.00 price target on shares of Andlauer Healthcare Group and gave the company a “buy” rating in a research report on Tuesday, January 17th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of C$57.43.

Insider Buying and Selling at Andlauer Healthcare Group

In other news, Senior Officer Stephen Barr sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, December 29th. The shares were sold at an average price of C$48.50, for a total value of C$242,500.00. Following the transaction, the insider now owns 20,498 shares in the company, valued at C$994,153. 1.82% of the stock is owned by company insiders.

Andlauer Healthcare Group Company Profile

(Get Rating)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.